Evidence map›Paper›PMID 36299188›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Alteration of Wnt3a overexpression and its early monitoring value during hepatocellular carcinogenesis].

M Yao, J J Wang, L L Wang, Y Y Qin, W L Sai, L Wang, S J Shen, Dengfu Yao

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. [Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

M YaoResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China Department of Immunology, Medical School of Nantong University, Nantong 226001, China.
J J WangJiangsu Nantong Higher Vocational and Technical School of Health, Nantong 226016.
L L WangDepartment of Immunology, Medical School of Nantong University, Nantong 226001, China.
Y Y QinDepartment of Immunology, Medical School of Nantong University, Nantong 226001, China.
W L SaiResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
L WangDepartment of Immunology, Medical School of Nantong University, Nantong 226001, China.
S J ShenResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China Department of Oncology, Nantong Hospital of Traditional Chinese Medicine, Nantong 226001, China.
Dengfu YaoResearch Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China.
Nantong University · CNAffiliated Hospital of Nantong University · CN

Funding

Nantong Science and Technology Program MS12020021National Natural Science Foundation 81873915, 31872738, 81673241NTU Medical Science and Technology Plan of China TDYX2021010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsPrecancerous Conditions2-AcetylaminofluoreneAnimalsCarcinogenesisRatsRats, Sprague-DawleyRNA, Messenger2-AcetylaminofluoreneRNA, Messenger

Identifiers

PMID36299188
PMCPMC12770043
OpenAlexW4307497982

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.